0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
BASF and Monsanto soybean seed treatment deal
Jul. 2, 2008
BASF and Monsanto have signed an exclusive agreement for a new fungicide seed treatment solution for soybeans in the United States. The new product contains BASF’s fungicidal seed treatment, F500 (pyraclostrobin), and is expected to be commercialised in conjunction with the launch of Monsanto’s second generation genetically modified glyphosate-tolerant Roundup Ready 2 Yield soybean next year. Under the agreement, Monsanto will have exclusive rights to market the new fungicide seed treatment in soybeans.
BASF says that the seed treatment, apart from providing disease protection, results in improved stand and extra vitality for the plant. “The product would be especially significant for Monsanto because of the added-value like enhanced seed vitality that one gets from the F500 seed treatment”, says BASF’s director of seed treatment and global strategic marketing, Hans-Jurgen Lutz. The company received US approval for its pyraclostrobin-based fungicidal seed treatment, Stamina in February.
Roundup Ready 2 Yield soybeans are a higher yielding version of Monsanto’s original Roundup Ready soybeans, and received commercial approval in the US and Canada in 2007 and in Japan, the Philippines and Taiwan earlier this year. The company plans its controlled commercial release on 1-2 million acres (400,000-800,000 ha) in 2009, with a full-scale launch on 5-6 million acres in 2010. “We feel the product will be the best seed treatment fungicide available to complement our new Roundup Ready 2 Yield soybean offering,” said Monsanto’s executive vice president, Carl Casale.
Monsanto treats more than 1,000 million lbs (453,600 tonnes) of seed each year and plans to establish a global seed treatment business to complement its seed and trait operation. The company has revealed plans to apply a proprietary seed treatment to all of its Roundup Ready 2 Yield soybeans. In April, it entered into an agreement with Bayer CropScience for a fungicidal seed treatment for maize. The deal concerned Bayers Vortex (ipconazole), which is expected to be commercialised in conjunction with the planned launch of Monsantos multiple insect-resistant SmartStax maize in 2010 in the US.
Source: AgroNews
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER